These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 20132490)
1. Secreted protein, acidic and rich in cysteine (SPARC) expression in astrocytic tumour cells negatively correlates with proliferation, while vascular SPARC expression is associated with patient survival. Capper D; Mittelbronn M; Goeppert B; Meyermann R; Schittenhelm J Neuropathol Appl Neurobiol; 2010 Apr; 36(3):183-97. PubMed ID: 20132490 [TBL] [Abstract][Full Text] [Related]
2. Patterns of SPARC expression and basement membrane intactness at the tumour-brain border of invasive meningiomas. Schittenhelm J; Mittelbronn M; Roser F; Tatagiba M; Mawrin C; Bornemann A Neuropathol Appl Neurobiol; 2006 Oct; 32(5):525-31. PubMed ID: 16972886 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas. Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125 [TBL] [Abstract][Full Text] [Related]
4. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma. Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078 [TBL] [Abstract][Full Text] [Related]
5. The PFKFB3 splice variant UBI2K4 is downregulated in high-grade astrocytomas and impedes the growth of U87 glioblastoma cells. Zscharnack K; Kessler R; Bleichert F; Warnke JP; Eschrich K Neuropathol Appl Neurobiol; 2009 Dec; 35(6):566-78. PubMed ID: 19490427 [TBL] [Abstract][Full Text] [Related]
6. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas. Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425 [TBL] [Abstract][Full Text] [Related]
7. Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes. Watkins G; Douglas-Jones A; Bryce R; Mansel RE; Jiang WG Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):267-72. PubMed ID: 15763438 [TBL] [Abstract][Full Text] [Related]
8. Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors. Vandeputte DA; Troost D; Leenstra S; Ijlst-Keizers H; Ramkema M; Bosch DA; Baas F; Das NK; Aronica E Glia; 2002 Jun; 38(4):329-38. PubMed ID: 12007145 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of tumour vessels in cytological squash smears of astrocytic tumours. Sato S; Sato Y; Marutsuka K; Takeshima H; Asada Y Cytopathology; 2011 Oct; 22(5):313-7. PubMed ID: 21039979 [TBL] [Abstract][Full Text] [Related]
10. Tenascin expression in astrocytomas correlates with angiogenesis. Zagzag D; Friedlander DR; Miller DC; Dosik J; Cangiarella J; Kostianovsky M; Cohen H; Grumet M; Greco MA Cancer Res; 1995 Feb; 55(4):907-14. PubMed ID: 7531617 [TBL] [Abstract][Full Text] [Related]
11. Tumour vascularity is of prognostic significance in adult, but not paediatric astrocytomas. Birlik B; Canda S; Ozer E Neuropathol Appl Neurobiol; 2006 Oct; 32(5):532-8. PubMed ID: 16972887 [TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix glycoproteins and diffusion barriers in human astrocytic tumours. Zámecník J; Vargová L; Homola A; Kodet R; Syková E Neuropathol Appl Neurobiol; 2004 Aug; 30(4):338-50. PubMed ID: 15305979 [TBL] [Abstract][Full Text] [Related]
13. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach. Capper D; Mittelbronn M; Meyermann R; Schittenhelm J Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865 [TBL] [Abstract][Full Text] [Related]
14. Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors. Erdamar S; Bagci P; Oz B; Dirican A J BUON; 2006; 11(2):213-6. PubMed ID: 17318973 [TBL] [Abstract][Full Text] [Related]
15. Fascin expression [corrected] in glial tumors and its prognostic significance in glioblastomas. Gunal A; Onguru O; Safali M; Beyzadeoglu M Neuropathology; 2008 Aug; 28(4):382-6. PubMed ID: 18298442 [TBL] [Abstract][Full Text] [Related]
16. Analysis of interleukin (IL)-8 expression in human astrocytomas: associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry. Samaras V; Piperi C; Levidou G; Zisakis A; Kavantzas N; Themistocleous MS; Boviatsis EI; Barbatis C; Lea RW; Kalofoutis A; Korkolopoulou P Hum Immunol; 2009 Jun; 70(6):391-7. PubMed ID: 19332096 [TBL] [Abstract][Full Text] [Related]
17. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Rempel SA; Dudas S; Ge S; Gutiérrez JA Clin Cancer Res; 2000 Jan; 6(1):102-11. PubMed ID: 10656438 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression. Yamashita K; Upadhay S; Mimori K; Inoue H; Mori M Cancer; 2003 May; 97(10):2412-9. PubMed ID: 12733139 [TBL] [Abstract][Full Text] [Related]
19. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis. Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042 [TBL] [Abstract][Full Text] [Related]